Hyperfine appoints Rob Fasciano, PhD, and Rafael O’Halloran, PhD, to help advance AI-powered MRI technology and scale next-gen imaging solutions.

GUILFORD, Conn., June 11, 2025--Hyperfine appoints Rob Fasciano, PhD, and Rafael O’Halloran, PhD, to help advance AI-powered MRI technology and scale next-gen imaging solutions. B. Riley analyst ...

Hyperfine (HYPR) announced FDA clearance that includes an entirely new portable MRI scanner powered by the proprietary Optive AI software. The ...

Department of Chemistry and Chemical Biology, The University of New Mexico, MSC03 2060, 1 University of New Mexico, Albuquerque, New Mexico 87131-0001, and Department of Chemistry, North Carolina ...

Hyperfine, Inc. (NASDAQ: HYPR), the company behind the world’s first FDA-cleared portable MRI system powered by artificial intelligence – the Swoop® system – has received FDA approval for ...

This clearance is the most significant innovation in the history of Hyperfine. We plan to launch the new Swoop® system across hospital and office settings in the US, and we believe the new Swoop ...

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared AI-powered portable MRI system for the brain ...

A detailed quantum chemical analysis of the underlying principles of hyperfine coupling in 3d transition metal complexes has been carried out. The explicit evaluation of one- and two-electron ...

Hyperfine (Nasdaq:HYPR) announced today that the FDA cleared its latest portable MRI scanner powered by proprietary AI software. The Guilford, Connecticut-based company says the clearance marks a ...